Benzinga | Jul 22, 2021 04:18PM EDT

Plus Therapeutics Q2 EPS $(0.25) Misses $(0.24) Estimate

Plus Therapeutics (NASDAQ:PSTV) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.24) by 4.17 percent. This is a 44.44 percent increase over losses of $(0.45) per share from the same period last year.